HAO
Haoxi Health Technology LimitedNASDAQCommunication ServicesAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
1.47
PEG
0.00
P/B
0.17
P/S
0.24
EV/EBITDA
0.30
DCF Value
$75.34
FCF Yield
-42.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
2.8%
Operating Margin
-6.1%
Net Margin
11.8%
ROE
21.5%
ROA
18.0%
ROIC
-9.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $8.8M | $4.1M | $1.42 |
| FY 2025 | $32.8M | $3.9M | $1.32 |
| Q2 2025 | $24.0M | $-232.5K | $-0.01 |
| Q4 2024 | $25.0M | $529.8K | $0.04 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Communication Services
Industry
—
Country
CN
Exchange
NASDAQ
Beta
-0.19
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.